nach oben

Neurological Sciences

Erschienen in:

01.06.2020 | COVID-19 | COVID-19 Zur Zeit gratis

The neurological manifestations of COVID-19: a review article

verfasst von: Hamid Reza Niazkar, Behdad Zibaee, Ali Nasimi, Narjes Bahri

Erschienen in: Neurological Sciences | Ausgabe 7/2020

Einloggen, um Zugang zu erhalten

Abstract

Results

Various neurological manifestations have been reported in the literature associated with COVID-19, which in the current study are classified into Central Nervous System (CNS) related manifestations including headache, dizziness, impaired consciousness, acute cerebrovascular disease, epilepsy, and Peripheral Nervous System (PNS) related manifestations such as hyposmia/anosmia, hypogeusia/ageusia, muscle pain, and Guillain-Barre syndrome.

Conclusion

During the current context of COVID-19 pandemic, physicians should be aware of wide spectrum of neurological COVID-19 sign and symptoms for early diagnosis and isolation of patients. In this regard, COVID-19 has been associated with many neurological manifestations such as confusion, anosmia, and ageusia. Also, various evidences support the possible CNS roles in the COVID-19 pathophysiology. In this regard, further investigation of CNS involvement of SARS-COV-2 is suggested.

WHO Coronavirus disease (COVID-2019) situation reports [Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports

Niazkar HR, Niazkar M (2020) COVID-19 international outbreak and the need for a suitable estimation model: a second-order polynomial equation with constant coefficients based on imported infected cases seems inadequate. Asian Pac J Trop Med 13(4):185–186. https://doi.org/10.4103/1995-7645.280234CrossRef

Niazkar M, Niazkar HR (2020) COVID-19 outbreak: application of multi-gene genetic programming to country-based prediction models. Electronic J Gen Med 17(5):em247. https://doi.org/10.29333/ejgm/8232CrossRef

Lauer SA, Grantz KH, Bi Q, Jones FK, Zheng Q, Meredith HR, Azman AS, Reich NG, Lessler J (2020) The incubation period of coronavirus disease 2019 (COVID-19) from publicly reported confirmed cases: estimation and application. Ann Intern Med 172(9):577–582. https://doi.org/10.7326/M20-0504CrossRefPubMed

Wu Y, Xu X, Chen Z, Duan J, Hashimoto K, Yang L et al (2020) Nervous system involvement after infection with COVID-19 and other coronaviruses. Brain Behav Immun. https://doi.org/10.1016/j.bbi.2020.03.031

Bai Y, Yao L, Wei T, Tian F, Jin D-Y, Chen L, Wang M (2020) Presumed asymptomatic carrier transmission of COVID-19. Jama. 323:1406. https://doi.org/10.1001/jama.2020.2565CrossRefPubMedPubMedCentral

Wang Y, Kang H, Liu X, Tong Z (2020) Combination of RT-qPCR testing and clinical features for diagnosis of COVID-19 facilitates management of SARS-CoV-2 outbreak. J Med Virol 92:538–539. https://doi.org/10.1002/jmv.25721CrossRefPubMed

Jiang F, Deng L, Zhang L, Cai Y, Cheung CW, Xia ZJJGIM (2020) Review of the clinical characteristics of coronavirus disease 2019 (COVID-19):1–5. https://doi.org/10.1007/s11606-020-05762-w

Azhideh A (2020) COVID-19 Neurological Manifestations. Int Clin Neurosci J 7(2):54. https://doi.org/10.34172/icnj.2020.01CrossRef

10.

Rodriguez-Morales AJ, Cardona-Ospina JA, Gutiérrez-Ocampo E, Villamizar-Peña R, Holguin-Rivera Y, Escalera-Antezana JP, Alvarado-Arnez LE, Bonilla-Aldana DK, Franco-Paredes C, Henao-Martinez AF, Paniz-Mondolfi A, Lagos-Grisales GJ, Ramírez-Vallejo E, Suárez JA, Zambrano LI, Villamil-Gómez WE, Balbin-Ramon GJ, Rabaan AA, Harapan H, Dhama K, Nishiura H, Kataoka H, Ahmad T, Sah R, Latin American Network of Coronavirus Disease 2019-COVID-19 Research (LANCOVID-19). Electronic address: https://www.lancovid.org (2020) Clinical, laboratory and imaging features of COVID-19: a systematic review and meta-analysis. Travel Med Infect Dis 101623:101623. https://doi.org/10.1016/j.tmaid.2020.101623CrossRef

11.

Wang Y, Wang Y, Chen Y, Qin QJJ (2020) Unique epidemiological and clinical features of the emerging 2019 novel coronavirus pneumonia (COVID-19) implicate special control measures. J Med Virol 92(6). https://doi.org/10.1002/jmv.25748

12.

Filatov A, Sharma P, Hindi F, Espinosa PS (2020) Neurological complications of coronavirus disease (COVID-19): encephalopathy. Cureus. 12(3):e7352. https://doi.org/10.7759/cureus.7352CrossRefPubMedPubMedCentral

13.

Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, Qiu Y, Wang J, Liu Y, Wei Y, Xia J', Yu T, Zhang X, Zhang L (2020) Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet 395(10223):507–513. https://doi.org/10.1016/S0140-6736(20)30211-7CrossRefPubMedPubMedCentral

14.

Sharifi-Razavi A, Karimi N, Rouhani N (2020) COVID-19 and intracerebral haemorrhage: causative or coincidental? New Microbes New Infect 35:100669. https://doi.org/10.1016/j.nmni.2020.100669CrossRefPubMedPubMedCentral

15.

Wang L, He W, Yu X, Hu D, Bao M, Liu H, Zhou J, Jiang H (2020) Coronavirus disease 2019 in elderly patients: characteristics and prognostic factors based on 4-week follow-up. J Inf Secur 80:639–645. https://doi.org/10.1016/j.jinf.2020.03.019CrossRef

16.

Morelli N, Rota E, Terracciano C, Immovilli P, Spallazzi M, Colombi D, Zaino D, Michieletti E, Guidetti D (2020) The baffling case of ischemic stroke disappearance from the casualty department in the COVID-19 era. Eur Neurol 1:1–3. https://doi.org/10.1159/000507666CrossRef

17.

Giannis D, Ziogas IA, Gianni P (2020) Coagulation disorders in coronavirus infected patients: COVID-19, SARS-CoV-1, MERS-CoV and lessons from the past. J Clin Virol 104362:104362. https://doi.org/10.1016/j.jcv.2020.104362CrossRef

18.

Violi F, Pastori D, Cangemi R, Pignatelli P, Loffredo L (2020) Hypercoagulation and antithrombotic treatment in coronavirus 2019: a new challenge. Thromb Haemost. https://doi.org/10.1055/s-0040-1710317

19.

Tang N, Bai H, Chen X, Gong J, Li D, Sun Z (2020) Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy. J Thromb Haemost 18:1094–1099. https://doi.org/10.1111/jth.14817CrossRefPubMed

20.

Karimi N, Sharifi Razavi A (2020) Rouhani NJIRCMJ. Frequent convulsive seizures in an adult patient with COVID-19: a case report. Iran Red Crescent Med J (In Press). https://doi.org/10.5812/ircmj.102828

21.

Yasri S, Wiwanikit V (2020) COVID-19 and epilepsy. Ann Indian Acad Neurol 23(7):43. https://doi.org/10.4103/aian.AIAN_254_20CrossRef

22.

Lu L, Xiong W, Liu D, Liu J, Yang D, Li N, Mu J, Guo J, Li W, Wang G, Gao H, Zhang Y, Lin M, Chen L, Shen S, Zhang H, Sander JW, Luo J, Chen S, Zhou D (2020) New-onset acute symptomatic seizure and risk factors in corona virus disease 2019: a retrospective multicenter study. Epilepsia. https://doi.org/10.1111/epi.16524

23.

Nicastri E, Petrosillo N, Bartoli TA, Lepore L, Mondi A, Palmieri F et al (2020) National Institute for the Infectious Diseases “L. Spallanzani”, IRCCS. Recommendations for COVID-19 clinical management. 12(1). https://doi.org/10.4081/idr.2020.8543

24.

Badyal DK, Mahajan RJIJA (2020) Research BM. Chloroquine 10(2):128. https://doi.org/10.4103/ijabmr.IJABMR_141_20CrossRef

25.

Libbey JE, Fujinami RSJF (2011) Neurotropic viral infections leading to epilepsy: focus on Theiler’s murine encephalomyelitis virus. 6(11):1339–1350. https://doi.org/10.2217/fvl.11.107

26.

Singhi PJDM (2011) Neurology C Infectious causes of seizures and epilepsy in the developing world. 53(7):600–609. https://doi.org/10.1111/j.1469-8749.2011.03928.x

27.

Moriguchi T, Harii N, Goto J, Harada D, Sugawara H, Takamino J et al (2020) A first case of meningitis/encephalitis associated with SARS-coronavirus-2. https://doi.org/10.1016/j.ijid.2020.03.062CrossRef

28.

Filatov A, Sharma P, Hindi F, Espinosa PSJC (2020) Neurological complications of coronavirus disease (covid-19): encephalopathy. 12(3):e7352. https://doi.org/10.7759/cureus.7352

29.

Ying W, Qian Y, Kun ZJRS, Pharmacy A (2020) Drugs supply and pharmaceutical care management practices at a designated hospital during the COVID-19 epidemic. https://doi.org/10.1016/j.sapharm.2020.04.001

30.

Poyiadji N, Shahin G, Noujaim D, Stone M, Patel S, Griffith B (2020) COVID-19–associated acute hemorrhagic necrotizing encephalopathy: CT and MRI features. Radiology. 201187:201187. https://doi.org/10.1148/radiol.2020201187CrossRef

31.

Kansagra SM, Gallentine WB (2011) Cytokine storm of acute necrotizing encephalopathy. Pediatr Neurol 45(6):400–402. https://doi.org/10.1016/j.pediatrneurol.2011.09.007CrossRefPubMed

32.

Baig AM (2020) Neurological manifestations in COVID-19 caused by SARS-CoV-2. CNS Neurosci Therapeut 26(5):499–501. https://doi.org/10.1111/cns.13372CrossRef

33.

McAbee GN, Brosgol Y, Pavlakis S, Agha R, Gaffoor M (2020) Encephalitis associated with COVID-19 infection in an 11 year-old child. Pediatr Neurol. https://doi.org/10.1016/j.pediatrneurol.2020.04.013

34.

Sedaghat Z, Karimi N (2020) Guillain Barre syndrome associated with COVID-19 infection: a case report. J Clin Neurosci. https://doi.org/10.1016/j.jocn.2020.04.062

35.

Vaira LA, Salzano G, Deiana G, De Riu G (2020) Anosmia and ageusia: common findings in COVID-19 patients. Laryngoscope. https://doi.org/10.1002/lary.28692

36.

Gane SB, Kelly C, Hopkins C (2020) Isolated sudden onset anosmia in COVID-19 infection. A novel syndrome. Rhinology. https://doi.org/10.4193/rhin20.114

37.

Ovesen T (2020) COVID-19 anosmia. Tidsskrift for Den norske legeforening. https://doi.org/10.4045/tidsskr.20.0302

38.

Xydakis MS, Dehgani-Mobaraki P, Holbrook EH, Geisthoff UW, Bauer C, Hautefort C, Herman P, Manley GT, Lyon DM, Hopkins C (2020) Smell and taste dysfunction in patients with COVID-19. Lancet Infect Dis. https://doi.org/10.1016/S1473-3099(20)30293-0

39.

Moein ST, Hashemian SM, Mansourafshar B, Khorram-Tousi A, Tabarsi P, Doty RL. Smell dysfunction: a biomarker for COVID-19. International Forum of Allergy & Rhinology 2020. https://doi.org/10.1002/alr.22587

40.

Villalba NL, Maouche Y, MBA O, Sosa ZC, Chahbazian JB, Syrovatkova A et al (2020) Anosmia and dysgeusia in the absence of other respiratory diseases: should COVID-19 infection be considered? Eur J Case Rep Int Med 7(4). https://doi.org/10.12890/2020_001641

41.

Vaira LA, Salzano G, Fois AG, Piombino P, De Riu G. Potential pathogenesis of ageusia and anosmia in COVID-19 patients. International Forum of Allergy & Rhinology 2020. https://doi.org/10.1002/alr.22593

42.

Liu Z, Xiao X, Wei X, Li J, Yang J, Tan H, Zhu J, Zhang Q, Wu J, Liu L (2020) Composition and divergence of coronavirus spike proteins and host ACE2 receptors predict potential intermediate hosts of SARS-CoV-2. J Med Virol 92(6):595–601. https://doi.org/10.1002/jmv.25726CrossRefPubMed

43.

Steardo L, Zorec R, Verkhratsky A (2020) Neuroinfection may potentially contribute to pathophysiology and clinical manifestations of COVID-19. Acta Physiol. https://doi.org/10.1111/apha.13473

Titel: The neurological manifestations of COVID-19: a review article
verfasst von: Hamid Reza Niazkar
Behdad Zibaee
Ali Nasimi
Narjes Bahri
Publikationsdatum: 01.06.2020
Verlag: Springer International Publishing
Schlagwörter: COVID-19
SARS-CoV-2
Diagnostik in der Infektiologie
Erschienen in: Neurological Sciences / Ausgabe 7/2020
Print ISSN: 1590-1874
Elektronische ISSN: 1590-3478
DOI: https://doi.org/10.1007/s10072-020-04486-3

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Neurologie

Akuter Schwindel: Wann lohnt sich eine MRT?

28.04.2024 Schwindel Nachrichten

Akuter Schwindel stellt oft eine diagnostische Herausforderung dar. Wie nützlich dabei eine MRT ist, hat eine Studie aus Finnland untersucht. Immerhin einer von sechs Patienten wurde mit akutem ischämischem Schlaganfall diagnostiziert.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Viel Bewegung in der Parkinsonforschung

25.04.2024 Parkinson-Krankheit Nachrichten

Neue arznei- und zellbasierte Ansätze, Frühdiagnose mit Bewegungssensoren, Rückenmarkstimulation gegen Gehblockaden – in der Parkinsonforschung tut sich einiges. Auf dem Deutschen Parkinsonkongress ging es auch viel um technische Innovationen.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Results

Conclusion

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 7/2020

Selection of treatment for ictal asystole patients based on EEG and ECG with temporary cardiac pacing

Chronic migraine long-term regular treatment with onabotulinumtoxinA: a retrospective real-life observational study up to 4 years of therapy

Unusual imaging appearance of a rare cortical ependymoma mimicking angiocentric glioma

Aggressive anti-LGI1 encephalitis defeated by one cycle of intravenous rituximab—a case report

Assessment of cutaneous axon-reflex responses to evaluate functional integrity of autonomic small nerve fibers